Who owns XILIO THERAPEUTICS INC?
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 650k | $5.5M | -93% | Mar 2026 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bain Capital Life Sciences Investors | Dec 2025 | 7.4M | $4.7M |
| Frazier Life Sciences Management | Dec 2025 | 5.9M | $3.8M |
| Point72 Asset Management | Dec 2025 | 4.0M | $2.6M |
| Sio Capital Management | Dec 2025 | 2.1M | $1.4M |
| Stempoint Capital | Dec 2025 | 2.0M | $1.3M |
| Merck & Co | Dec 2025 | 1.5M | $950k |
| Empery Asset Management | Dec 2025 | 1.2M | $757k |
| Ghisallo Capital Management | Dec 2025 | 1.1M | $713k |
| Morgan Stanley | Dec 2025 | 840k | $538k |
| AJU IB Investment | Dec 2025 | 668k | $428k |